1251-1260 of 4127 results

Allens advises Octopus Australia on launch of renewable energy funds
News 21 Jul 2022

OASIS and OREO will co-invest into an Australian renewable energy portfolio, across wind, solar and storage projects. The investment platform will finance the entire renewable energy life cycle fro ...

Allens tops mid-year M&A league tables
News 19 Jul 2022

Allens ranked first for deal value in the announced Australasian M&A league tables in both the Mergermarket and Bloomberg rankings, and second in the Refinitiv rankings. The firm also topped ...

Employment and Safety: Key employment changes from 1 July 2022 and other developments
Insight 18 Jul 2022

The latest issues, decisions and proposed changes impacting business and workplace risk ...

More detail on the ESB's proposed capacity mechanism
Insight 14 Jul 2022

With so much recent commentary on the perks and pitfalls of a capacity mechanism, this Insight takes a step back and unpacks what we know about the proposal and what it will look like for both generators and retailers in the future. ...

National Electricity and Gas rules update: June 2022
Insight 13 Jul 2022

In our latest update, we examine the progress of new and existing rule change requests to the AEMC across the month of June, as well as take a closer look at the AEMC's draft report to improve certainty on the delivery of transmission required for the transition to net zero. ...

Allens advises Igneo Infrastructure Partners on the acquisition of Elliott Green Power Australia
News 05 Jul 2022

Under the deal, Atmos Renewables has acquired EGP's portfolio of the Childers, Susan River and Nevertire solar farms with a combined capacity of 302 MW, generating approximately 500GWh of energy ...

Allens advises Liontown on world-class Kathleen Valley Lithium Project
News 01 Jul 2022

With the execution of the third offtake agreement and funding facility with Ford, the Liontown Board made the Final Investment Decision to proceed to develop the project. 'This is a significant ...

The mRNA rush
Insight 30 Jun 2022

There is great potential for mRNA technology to revolutionise future vaccines, and treatment of various conditions such as rare genetic disorders, other infectious diseases and even cancer. The enthusiasm for the technology – or the 'mRNA rush' – is reflected by a spike in patent filings over the past five years, and the growing patent portfolios of key mRNA pioneers and market players. ...

Consultation sought on Queensland's privacy and right to information reforms
Insight 30 Jun 2022

The recently released consultation paper on Queensland's privacy and right to information framework outlines significant proposed reforms. This Insight explains the key suggested changes and their potential impacts. ...

Refine